SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001999371-24-007476
Filing Date
2024-06-14
Accepted
2024-06-14 17:25:33
Documents
16
Period of Report
2024-06-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K tnxp-8ka_061124.htm   iXBRL 8-K/A 34677
2 OPINION OF LOWENSTEIN SANDLER LLP ex5-02.htm EX-5.02 10156
6 GRAPHIC tnxp_001.jpg GRAPHIC 3955
7 GRAPHIC tnxp_002.jpg GRAPHIC 3955
  Complete submission text file 0001999371-24-007476.txt   234519

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tnxp-20240611.xsd EX-101.SCH 3024
4 XBRL LABEL FILE tnxp-20240611_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE tnxp-20240611_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8ka_061124_htm.xml XML 3950
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36019 | Film No.: 241046087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)